Join the Neurogenic Bladder group to help and get support from people like you.
Neurogenic Bladder News
Factors ID'd for Clean Intermittent Catheterization Compliance in Youth With Neurogenic Bladder
WEDNESDAY, May 8, 2024 – For children with neurogenic bladder, self-catheterization is associated with lower adherence to clean intermittent catheterization (CIC), according to a study recently...
Augmentation Cystoplasty Safe for Children With Neurogenic Bladder
WEDNESDAY, March 6, 2024 – For children with neurogenic bladder, augmentation cystoplasty (AC) is safe and effective, with low surgical and metabolic complication rates, according to a study...
Pediatric Neurogenic Bladder Cases Are Not Fully Evaluated
FRIDAY, Nov. 3, 2023 – Pediatric neurogenic bladder (NGB) cases are not fully evaluated in routine clinical practice, according to a study published online Oct. 16 in Advances in Therapy. Naoko...
Pelvic Floor Muscle Training No Better Than Bladder Training for Overactive Bladder
MONDAY, Oct. 2, 2023 – For women with overactive bladder symptoms, supervised pelvic floor muscle training (PFMT) does not provide additional improvement over bladder training, according to a study...
Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder
THURSDAY, Sept. 7, 2023 – Early clean intermittent catheterization is recommended to reduce the incidence of recurrent febrile urinary tract infections (FUTIs) in children with neurogenic bladder...
Botox (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved Botox® for the treatment of ...
FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Neurogenic Detrusor Overactivity (NDO) Pediatric Patients
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA)...
Ask a question
To post your own question to this support group, sign in or create an account.